A carregar...
Practical management of tumour lysis syndrome in venetoclax‐treated patients with chronic lymphocytic leukaemia
The treatment landscape in relapsed/refractory chronic lymphocytic leukaemia (CLL) has rapidly evolved over the past five years, with one such emergent treatment being the BCL2 inhibitor, venetoclax. This oral treatment has demonstrated significant clinical advantages in indicated patients, but rapi...
Na minha lista:
| Publicado no: | Br J Haematol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7154710/ https://ncbi.nlm.nih.gov/pubmed/31858596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16345 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|